New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 31, 2013
07:43 EDTAMRNAmarin receives two new patent allowances related to Vascepa
Amarin announced that the United States Patent and Trademark Office, or USPTO, has published notification of Notices of Allowance for Amarin's U.S. Patent Applications Serial Numbers 13/458,496 and 13/349,157. The allowed '496 and '157 applications continue to broaden our claimed methods of reducing triglycerides consistent with the FDA approved MARINE indication for Vascepa capsules through use of a pharmaceutical composition of highly pure icosapent ethyl, or EPA. A Notice of Allowance is issued after the USPTO makes a determination that a patent can be granted from an application. The issued patents would have terms that expire no earlier than in 2030. After issuance, Amarin plans to list these patents in the FDA's Approved Drug Products with Therapeutic Equivalence Evaluations, or Orange Book.
News For AMRN From The Last 14 Days
Check below for free stories on AMRN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 31, 2014
11:20 EDTAMRNHigh option volume stocks:
High option volume stocks: AMRN EWT HIMX PTEN URBN MTW VPRT MTH OTEX ZLTQ
09:26 EDTAMRNOn The Fly: Pre-market Movers
Subscribe for More Information
09:11 EDTAMRNAmarin up 12% to $1.78 after positive mention by Adam Feuerstein
Subscribe for More Information
09:10 EDTAMRNAmarin mentioned positively by The Street's Adam Feuerstein
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use